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The authors describe a modification ofthe instrumentalparameters
of the Diamat fully automated HPLC system for Hb A2 assay
(Bio-Rad Laboratories, Milan, Italy) in order to obtain
simultaneous determination ofHb A2 and Hb F.
Hb Az and Hb F measurements are reproducible (within-run CV
2"6%, with Hb A 2"7%; 5"1%, with Hb F 1"3%) and accurate
(from a comparison with two microchromatographic techniquesfor
Hb A: r 0"9639 and 0"9755; with two alkali denaturation
procedures for Hb F: r 0"9990 and 0"9952; with radial
immunodiffusion, r 0"9877). Assay linearity has been confirmed
for Hb A concentrations between 0 and 6"0%, and for Hb F
between 0 and 60%. The data obtainedfrom the analysis ofsome
pathological samplesfor Hb Bart’s, Hb H, HbJ Sardegna, Hb
Lepore and Hb S are in agreement with cellulose acetate
electrophoresis analysis.
The Hb A2 reference intervals for normals (N 597) and
Beta-thalassemia carriers (N 200) are respectively (95%
limits) 2"02-3.27 and 3"92-5"90 in % units. Hb F values
measured in normals (N 968), in -thal carriers (N 302) and
in 6[3-thal carriers (N 3) have beenfound to be consistent with
the usual diagnostic parameters.
Some minor limitations emerged: the most relevant concerns Hb
Alc, which is overestimated with respect to a reference method (y
1"217x + 0"16; N 79; r 0"9235). A probable interference
from labilefractions is responsiblefor this Hb Ac inaccuracy.
Introduction
The determination of the minor haemoglobins, Hb A2
and Hb F, in whole blood are of considerable diagnostic
use for the characterization of several thalassaemic
syndromes and for the correct diagnosis of several
haemoglobinopathies [1]. It is also known that elevated
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levels of Hb F can be associated with neoplastic
conditions, anaemias and leukaemias of different etiolo-
gies [2]. Therefore, a variety of laboratory techniques
have been developed to accurately measure these minor
haemoglobins. The most commonly used are ion-
exchange chromatography [3], on microcolumns or with
HPLC [4-7], for Hb A2, and radial immunodiffusion [8]
and alkali denaturation [9-11] for Hb F.
This report presents the authors’ experience with a new
HPLC method performing a simultaneous determination
of Hb A and Hb F. This is obtained by using a fully
automated HPLC analyser (Diamat, Bio-Rad Lab-
oratories, Segrate, Milan, Italy), originally dedicated to
the analysis of glycated haemoglobins [12-14], and later
adapted to Hb A determination [15].
By introducing a slight modification to the buffer elution
times recommended by the manufacturer for Hb A
determination, the method was adapted for measuring
Hb A2 and Hb F simultaneously.
The data reported here confirm the utility of the
technique to haematological practice. Some minor limi-
tations are also discussed.
Materials and methods
Samples
Whole blood samples (anticoagulated with potassium
EDTA, g/l) were selected from routine laboratory
samples for most ofthe analytical tests. Informed consent
was obtained from those subjects studied for the evalu-
ation of reference values.
Stabilized HbA and Hb F liquid control materials were
obtained by adding ethylene glycol (0"35 volume frac-
tion) to haemolysates prepared by a standard tetra-
chloromthane lysis procedure 16]. These solutions total
Hb 100 + 20 g/l) were stored at -20C and used for long-
term precision estimates. This was carried out by
assaying two haemolysates, with low and high Hb A2 and
Hb F concentrations, over periods of about one month
(the HbA test) and three months (the Hb F test).
Procedures
Diamat HPLC analysis
This method basically consists of a cation-exchange
liquid chromatography developed with three tris-
phosphate buffers of increasing ionic strength at a
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controlled temperature of23 C. The eluate is read at 415
and 690 nm. For the analysis five tl of whole blood are
diluted, by means of the dilutor supplied with the
apparatus, with ml ofhaemolizing reagent. The haemo-
lysate is centrifuged at 10 000 g for min and is then
loaded into the sample compartment, which is kept at
between 2 and 8C. Twentytl are injected into the
column for each run.
Figure shows the modifications made to the instrumen-
tal parameters recommended by the manufacturer in
order to obtain a resolution of Hb F from Hb Alc. The
best Hb F isolation is achieved by prolonging the buffer
elution to 2 min (figure l[c]); there is no effect if the
elution of buffer 2 is prolonged from 6"4 to 9"4 min.
Therefore, after these tests, it was decided to adopt the
following instrumental parameters: injection interval
170; injection volume 2; stepwise time 20; stepwise
time 2 77; stepwise time 3 140; stop time 9900; off
time 800; response time 1"00 (for all the minor
fractions).
The flow is critical for optimal resolution of the Hb F
peak: a flow of ml/min is obtained by setting the
internal knob to a position between 25 and 30. The
operating pressure, under such conditions, is between 55
and 60 kg/cm2. By using these parameters the haemaglo-
bins are eluted in the following order (retention times in
parentheses, and given in min): Hb Ala and Alb (1"7), Alc
(3"1), F (3"9), A0 (7"5), A2 (9"9); each run takes
approximately 16"5 min.
Columns and reagents used within this evaluation were
from Bio-Rad HF and KK batches. All the chromato-
grams in figures 1-3 have been redrawn from the original
paper print-out.
Reference methods
Alternative chromatographic procedures for Hb A2 have
been performed either according to ICSH recommenda-
tions [3, 17] or by using disposable microcolumns (Beta-
Thal Quick Column, Helena Laboratories, Milan, Italy).
The average within-run imprecision for Hb A2 deter-
minations by these methods (data from two different
laboratories) are:
(1) ICSH method: CV 14"3% (Hb A 2"58%) and
3"7% (HbA 5"86%).
(2) Microcolumns: CV 2"8% (Hb A 2"49%) and
1"2% (HbA 5"22%).
As Hb F reference methods the following were used:
(a) Alkali denaturation, method [9].
(b) Alkali denaturation, method 2 [11].
(c) Radial immunodiffusion for samples with Hb F
lower than 12%
(d) Diamat analysis for Hb Alc (see later).
The within-run imprecisions ofthese methods (as CV) for
Hb F concentrations between 0"8 and 2"2% are: 7"3%
(method a), 8"0% (method b), 4"3% (method c) and 3"3%
(method d).
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Figure 1. Effect ofthe elongation of buffers elution time (e.t.) on
the resolution between Hb Ale and Hb F. (a): instrumental
parameters as recommended by Bio-Rad Laboratories; (b)-(d):
tested modifications. (a): Buffer 1 e.t.: l’Omin; buffer 2e.t.:
6"4min. (b): Buffer 1 e.t.: 1.5min; buffer 2e.t.: 6"4min. (c):
Buffer 1 e.t.: 2"Omin; buffer 2e.t.: 6"4 min. (d): Buffer 1 e.t.:
2"0 min; buffer 2 e.t.: 9"4 min. The ordinate axis (absorbance) is
automatically set to a fixed percentage offull scale (typically
10%), when Hb AIc is precisely located. The x-axis is the elution
time (min). The scales ofgraphs (a)-(c) are the same asfor (d).
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Figure 2. Chromatograms obtainedfrom the analysis ofa normal subject (a), a [-thalassaemia carrier (b), a [-homozygous (c) and a
double heterozygousfor [-thal andHb S (d). The relative concentrations ofthe different haemoglobin components are reported inparentheses,
in % unit. (b), (c) and (d) x-axis scales as in (a).
As Hb Alc reference method another Diamat instrument
was used, which was dedicated to Hb Ale measurement
for the diabetic centre (later called the x-method). This
instrument is equipped with a different column and buffer
elution system; and its analytical characteristics have
previously been evaluated [12-14]. Each blood sample
was therefore treated independently for each analysis and
loaded on the two instruments almost simultaneously
(or at least no longer than 12h between the two
determinations).
Statistical analysis
All the statistics have been calculated on an IBM
personal computer by using parametric tests. Hb A2
values in normals and in [-thal carriers were found
to be normally distributed, as evaluated by
Kolmogorov-Smirnov test [18] and asymmetry and
curtosis coefficients. The determination of the reference
limits was performed according to the IFCC recommen-
dations 19].
Results
Chromatographic resolution ofminor and abnormal haemoglobins
Some typical chromatograms obtained by the Diamat
analyser are reported in figures 2 and 3. As can be seen
from figure 2(a), Hb F is normally not resolved if its
concentration is below 1%. When an abnormal peak is
isolated, this is reported as an unknown fraction which
has to be interpreted from the chromatogram. The small
peak between Hb F and Hb A0 (figures 2[b] and [d]) is
usually absent, and, if present, never exceeds 1.5% of
total haemoglobin. This can probably be identified as Hb
Aid, an adduct ofhaemoglobin and oxidized glutathione
[0].
Surprisingly, in the case of [3-thalassaemic homozygous
(figure 2[c]) a small percentage of Hb A0 and an
abnormal Hb Ac peak was found. Complete absence of
Hb A0 in this subject has been demonstrated by DNA
analysis with synthetic oligonucleotides [21], which
showed a mutation at codon [339 (CAG TAG). This
kind of mutation is responsible for more than 95% of all
cases of [3-thalassaemia in Sardinia. Therefore, the small
fraction detected as Hb A0 is probably an artefact, or
some unidentified component.
As regards to Hb Alc, a significant amount of acetylated
Hb F is probably responsible for the elevation ofthe peak;
from a comparative study with isoelectric focusing on
cord blood samples, it has been shown that Hb F is eluted
among Hb A fractions (data not shown here).
Hb H and Hb Bart’s (figures 3[a] and [b]) are eluted
before the Hb A1 fractions; this is in agreement with data
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Figure S. Chromatogramsfrom." a subject sufferingfrom HbH disease (a), a newborn with Hb Bart’s (b), an Hb Lepore (c) and an HbJ
Sardegna carrier (d).
reported when using a similar cation-exchange HPLC
procedure [20]. Hb Lepore (figure 3[c]) is slightly
underestimated with respect to densitometric analysis
(10"3% versus 15"0%, respectively).
Figure 3(d) reports on a case of a Hb J Sardegna (050
[CE8] His Asp) carrier; as frequently happens in such
cases, ifthe Hb A lc is not resolved, the absorbance scale is
automatically set to 100%. The haemoglobin variant is
eluted among the Hb A1 fractions in agreement with its
’fast’ electrophoretic mobility and is correctly quantitated
(about 19%, against the 20"5% obtained by densitometry
of the electrophoretic trace).
Accuracy of Hb Ac determination has been tested by
analysing several samples, from normal and diabetic
subjects, using the two Diamat procedures. The results of
such a comparison are reported in figure 4.
Analytical performance
Total imprecision ofthe method was tested separately for
Hb A2 and Hb F by analysing several samples from
normals and [3-thal carriers. The results are reported in
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Figure 4. Comparison between the present method (y) and a
reference method (x) for gb Ale quantification: y 1"217x +
0"16; n 79; r 0"9235; Sy, 0"99.
table 1. The Hb A2 determination is highly reproducible
(CV never exceeding 4%). Acceptable imprecision has
also been found for Hb F; only for concentrations in the
range of 1% or lower are the CVs significantly higher.
Linearity was evaluated by measuring in duplicate
different haemoglobin solutions prepared by mixing HbA. Mosca et al. Evaluation of the Diamat HPLC for haemoglobin determination
Table 1. Analytical imprecision.
Hb A2 Hb F
CV CV
N Mean+ SD % N Mean_ SD %
Within-Run
Normal
Abnormal-1
Abnormal-2
Between-run
Normal
Abnormal
10 2"71 4- 0.07 2"6 10 1"30 4- 0"07 5"1
10 5"22 + 0"15 2"9 10 3"47 + 0"14 4"1
10 7.94+ 0"20 2"5
15 2"82 + 0"10 3"6 17 0"71 4- 0"19 27"0
15 4"03 4- 0’16 3"9 22 3"91 4- 0"13 3’2
A0 and Hb A2, isolated by convdntional liquid chromato-
graphy (Hb A2 linearity test) or saline washed erythro-
cytes obtained from a normal subject and cord blood (Hb
F linearity test).
The HPLC procedure for these measurements is linear
for HbA concentrations up to 6% (y 0"94x + 0"45; r
0"992; Sy, 0"22) and for Hb F values up to 34% (y
1"42x 0"37; r 0"998; Syx 0"88). However, acceptable
Hb F measurement can be taken even at higher Hb F
concentrations, up to 60% (y l’08x + 2"44; r 0"990;
(1) Normals
(N 597)
(2) [3-thal
carriers
(N 200)
Mean + SD: 2"64 + 0"32
95% confidence
interval: 2"02- 3"27%
Mean + SD: 4"91 _+ 0"51%
95% confidence
interval: 3"92- 5"90%.
The cut-offlimit can be set at HbA 3"35%; out of the
797 subjects only three had HbA values between 3"4 and
3"6%.
Hb F values in normals and in different thalassaemia
syndromes carriers were distributed as follows. Hb F
concentrations higher than 1"0% were measured in:
(a) 44 out of 192 normal young subjects (age 1-14
years, 22"9%) and in 41 out of 776 normal adults
(5.%).
(b) 38 out of 65 [-thal young carriers (age 1-14 years,
58"5%) and in 81 out of237 [-thal adults (34"2%).
Hb F concentrations in three non-deletion -
thalassaemia carriers, Sardinian type [22] were: 14"1 +
1"7% (mean + SD).
Discussion
Accuracy was tested by making a comparison of the
Diamat proposed procedure against several reference
methods, as reported in table 2. The correlations between
these methods were excellent.
Finally, the procedure has no carry-over and is insensitive
to changes in sample total haemoglobin, in the range 4"4-
20"4 g/dl (data not reported in detail).
With regards to column life, we found that Hb F can be
properly resolved for up to 750-800 runs. Up to 1100 runs
ofHb A can be made.
Reference values
Hb A2 reference values were evaluated for normal adults
and -thal carriers. From the statistical analysis of
elementary data the following values were obtained:
The authors first experiences with the Diamat system
applied to the determination of haemoglobin species in
blood are reported. It is clear that this apparatus can
improve routine haematological management in the
clinical laboratory. The system offers the following
advantages:
(1) Hb A is measured accurately and reproducibly.
This is relevant because HbA accounts for only a
small amount of total haemoglobin (Hb A con-
centrations higher than 6% are rarely found) and
because the separation limit between normals and
[3-thalassaemics is very narrow. A similar reprodu-
cibility is rarely obtained with manual chromato-
graphic methods.
The reference intervals found for normals and [3-
thalassaemia carriers are in agreement with those
already reported [3].
Table 2. Relevant linear regression parameters concerning the comparison among the Diamat method (y) and different techniquesfor Hb A2
and Hb F determination (x-methods).
x-method N Slope 4- SD Int. 4- SD Sy, Range, % r
Hb A2
Hb F
Ion-exchange 70 0"883 4- 0"030 0"33 4- 0"12 0"30 2"0-6"0 0"9639
Ion-exchange (Helena) 200 0"942 4- 0"015 0"36 4- 0-06 0"28 1"6-5"9 0"9755
Alkali den. 30 1"078 4- 0"011 -0"60 4- 0"20 0"98 1"3-55"0b 0"9990
Alkali den.d 49 1"016 4- 0"005 -0"12 4- 0"23 0"83 12"0-80"0
b 0"9995
Radial imrn.d 31 1"040 4- 0’031 0" 17 4- 0" 17 0"52 0"5-12"0b 0"9877
Diamat-Alc 31 1.030 4- 0"013 0"20 4- 0"30 1.39 1"1-65"0b 0"9980
a: Minimum and maximum HbA concentrations determined by x-method.
b: Minimum and maximum Hb F concentrations determined by x-method.
c: According to ref. 11].
d: According to ref. [9].
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Simultaneous Hb F determination eliminates the
need for separate analysis; this kind of measure-
ment is, for most Hb F assay protocols, time-
consuming, poorly reproducible and seldom linear
to high concentrations.
Chromatographic analysis is able to discriminate
between several haemoglobin variants; their quan-
tification is, in the majority of cases, in agreement
with the electrophoretic pattern.
Sampler capacity (48 tubes) and the system’s
automation allow up to 90 samples per day to be
analysed; no special skills are required to operate
the instrument.
A cation exchange HPLC analysis recently proposed by
Bisse and Wieland [20] seems to offer similar advantages.
The system optimized by these authors is probably
superior, in terms of resolution, but compared to the
Diamat procedure, has the following drawbacks:
(b)
(c)
The analysis is more time-consuming (each run
takes more than 60 rain, while the Diamat run is
only one-third as long).
No information is available on accuracy in Hb A2
measurement.
Hb A lc accuracy has been evaluated on a small
number of subjects (N 25), with only three of
these subjects out of normal range.
No other fast high resolution HPLC procedure for the
separation ofHb F, Hb A0, Hb A2 and other Hb variants
seems to have been presented.
The Diamat system has some minor problems. For
example Hb Alc quantification seems to be overestimated
with respect to a reference method of proved accuracy
[12]. A possible explanation for this could be the
influence of labile aldimine forms which, if not removed
during the haemolysis step, can co-migrate with the Hb
Alc component (stable ketoamine form). The importance
of removing these labile forms has been stressed by
several investigators [23-25]. It has also been demon-
strated that the Diamat Alc analysis (the x-method in
figure 4) is specific for the stable forms [25]. In fact, a
significative difference has been found by analysing the
haemolysing agent used for Hb Ale determination (x-
method) and the one used with the test method (y-
method in figure 4); the two agents differ in pH (5"95
versus 7"20, respectively) and in conductivity (246 versus
132tS, respectively). In order to confirm that the
haemolysing agent has a powerful effect on Hb Ale
concentration, Hb Alc was measured using the proposed
method, in a sample treated with the two haemolysing
agents separately. The following values were found: 5"3%
(x-method haemolysing solution) and 7"3% (y-method
haemolysing solution). In conclusion, the Hb Alc
measurement on Diamat equipped with reagents and
column for Hb A and Hb F is probably inaccurate,
because the labile aldimine form is not removed during
the haemolysis step.
A second limitation of the technique concerns peak
identification. This is easily done for normal samples,
but, when dealing with abnormal samples (for example
those reported in figures 2 and 3) peak identification
should be performed by an experienced haematologist. It
is also evident that, if a pathological result is obtained,
further analyses, such as DNA analysis and globin chain
synthesis, have to be made in order to obtain a final
diagnosis.
Apart from these limitations, this kind ofHPLC analysis
is useful for diagnosis of haemoglobin-related disorders.
Improvements, such as a further reduction of analysis
times for a correct estimation oflib Alc, would be useful.
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